FinscoFinsco

Clover Health (US.CLOV)

Capital Allocation Audit · Period: 2019 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.CLOV · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion99.2%→
ROE8.1%↑
Cash Conversion394.7%→
D/E Ratio0.00↓
Gross Margin21.3%↓
US.CLOV (Clover Health) | YoY: 2026 Q1 vs 2025 Q1


Metric            Value  YoY
----------------------------
FCF Conversion    99.2%    →
ROE                8.1%    ↑
Cash Conversion  394.7%    →
D/E Ratio          0.00    ↓
Gross Margin      21.3%    ↓
Key Metrics
US.CLOV (Clover Health) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
----------------------------
FCF Conversion 99.2% →
ROE 8.1% ↑
Cash Conversion 394.7% →
D/E Ratio 0.00 ↓
Gross Margin 21.3% ↓

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies